Country for PR: United Kingdom
Contributor: PR Newswire Europe
Thursday, December 24 2020 - 11:00
Lycovary(TM) Daily provides anti-ageing oxygenation of the ovaries to help women with PMS, painful periods and comfortable menopause transition
CAMBRIDGE, England, Dec. 24, 2020 /PRNewswire-AsiaNet/ --

Cambridge Diagnostic Imaging, CaDi, ( is 
launching Lycovary(TM) Daily, a new generation of food supplement for ovarian 
health in the family of oxygenation products. It provides clinically validated 
and personalised daily support for women from the beginning of their fertile 
phase through to the menopause. 

Hundreds of millions of women around the world encounter problems before and 
during their periods due to ovarian hormonal imbalances. In addition, hot 
flushes and night sweats during the menopause, early onset of osteoporosis and 
other health issues in later life also stem from this imbalance.

Tissue oxygenation is essential for any tissue function, including hormone 
production. This oxygenation gradually declines naturally with age. However, 
tissue oxygen deprivation may happen at any age, caused by certain dietary 
deficiencies, negative lifestyle factors or inflammatory conditions. This in 
turn would lead to disruption in synchronisation of the ovarian hormone cascade.

Lycovary(TM) Daily has been developed by Lycotec [], a 
biotech company based in Cambridge UK. It is a patented complex of DHA Omega 3 
with the carotenoid molecules Lutein and Zeaxanthin, which, due to a unique 
technology, can provide targeted anti-ageing oxygenation for women throughout 
their life.

Clinical trials 
age=148;epage=154;aulast=Petyaev] demonstrated 250 mg of Lycovary(TM) Daily DHA 
Omega 3 to be 10-16 times stronger than conventional Omega 3 supplement 
products and 4–5 times more powerful than Omega 3 pharmaceuticals. This 
superiority translates into a much more efficient reduction in markers of 
inflammatory damage and to a boost in peripheral tissue oxygenation and 
respiration. The increased bioavailability and targeted delivery reduces side 
effects and makes for unnecessary overconsumption of traditional Omega 3 and 
carotenoid products.

CaDi, a member of the International Association of Fertility Societies 
[], helps with ovarian health problems which 
affect half of the world's female population. About 30-40% of women of 
reproductive age have premenstrual syndrome (PMS), and about 50% dysmenorrhea, 
of whom 15-20% have severe painful periods. 45-50% of all women have adverse 
menopausal symptoms.

"We are pleased to announce that CaDi is launching Lycovary(TM) Daily to help 
women to support their health and improve the quality of their lives. We are 
proud that many years of medical research have now resulted in a powerful and 
effective dietary supplement, which will be available worldwide from the 
beginning of next year," said Alex Shulepov, CEO of CaDi. 

A combination of Lycovary(TM) Daily with a personalised CaDi AI-based algorithm 
recommendation provides additional superior efficacy over existing Omega 3 and 
carotenoid products. It is safe, vegan and its active ingredients are GMO-free 
and approved for humans.

CaDi Family products are available only on

For further information please contact

Source: Cambridge Diagnostic Imaging (CaDi)